GBI Research, Jan 2011, Pages: 96
insight of reasons for outsourcing clinicaltrials to India and the key services provided by the CROs of India. The report also provides a detailed analysis of the Indian market in terms of its size
GBI Research, July 2011, Pages: 103
and a comparative analysis of clinicaltrial registration in Brazil, Russia, India and China (BRIC) and six major Latin American countries.
- Analysis of the key drivers that are fueling the growth of the clinical
GBI Research, Sep 2011, Pages: 98
-2017) 29
4.3.1 Brazil 29
4.3.2 India 30
4.3.3 China 31
4.4 Patient Recruitment for Hypertension 32
4.4.1 Number of Patients Recruited by Phase of ClinicalTrial 32
4.4.2 Number of Patients Recruited by Major
GBI Research, Sep 2011, Pages: 97
of ClinicalTrials by Geography 27
4.2.4 Number of ClinicalTrials by Year 28
4.3 Prevalence Population for Alzheimer’s disease (2010-2017) 29
4.3.1 Brazil 29
4.3.2 India 30
4.3.3 China 31
4.4 Patient
GlobalData, April 2011, Pages: 97
4.4 Registration of Phase lV ClinicalTrials
4.5 ClinicalTrials Registered in 2010
4.6 Comparative Analysis of Registered ClinicalTrials in Brazil, Russia, India and China (BRIC) Countries
4
GBI Research, June 2011, Pages: 78
.3.7 Biopharmaceutical Companies Benefit from New Technologies that a CRO Has Access to 55
9.4 Cost of ClinicalTrial is reduced by Outsourcing by a Significant Amount 56
9.4.1 Cost of Conducting ClinicalTrials in India
Business Insights, June 2009, Pages: 287
published by Business Insights that provides a comprehensive examination of the clinicaltrial landscape in emerging countries, with specific focus on China, India, Central and Eastern Europe
Elsevier Science and Technology, July 2011, Pages: 522
and providing insight into the logistical challenges including language barriers, this book provides a working tool for clinical researchers and administrators to navigate the intricacies of clinicaltrials
GBI Research, Sep 2011, Pages: 82
to Phase III ClinicalTrials 11
3.6 Pharmaceutical Industry and Drug Safety Challenges 12
3.7 Post Marketing Clinical Research: an Unavoidable Necessity for the Pharmaceutical Industry 13
3.7.1 Phase IIIb
Ankur Mittal, Oct 2011, Pages: 102
and the industrial sectors, in addition to other auxiliary sectors across the continents.
The directory covers a total of 98 Contract Research Organizations (both domestic & global) having operations in India
Business Insights, July 2010, Pages: 198
types of industryclinicaltrials involving PET
Table 8.21: Examples of the different types of industryclinicaltrials involving MRI
Table 8.22: Effect of HER2 testing on the development of Herceptin
Global Industry Analysts, Inc., April 2010, Pages: 490
FDA Clearance for ClinicalTrials on NE-180 II-33
6. RECENT INDUSTRY ACTIVITY II-34
Affymax Receives Milestone Payment from Takeda for Hematide II-34
AMAG and Takeda Ink Licensing Deal II-34
District
Global Industry Analysts, Inc., Feb 2011, Pages: 682
9. RECENT INDUSTRY ACTIVITY 75
Genentech to Carry Out Additional Trial of Avastin in Her2-
negative mBC 75
Pfizer to Seek regulatory Clearance for Axitinib in Europe and US 75
FDA to Withdraw
NeuroInsights, May 2011, Pages +: 500
in clinicaltrials (and abandoned) by company, mechanism of action and stage of development for each indication
- Global and US market size, worldwide revenues for each indication
- Extensive discussion
GBI Research, June 2011, Pages: 93
Model Service Provider 56
5.11.7 Outsourcing to India 57
5.11.8 Cost of Setting up a Clinical Data Management Setup in India 58
5.11.9 Case Studies 59
5.12 CDISC Standards & Compliance 60
5.12.1 SDTM 60
5
Arrowhead Publishers, May 2010, Pages: 261
are the major challenges in this market and how can these be overcome?
- How will pharmacogenomics transform clinicaltrials?
- What are the leading pharmacogenomic products on the market?
- Who are the key
